Free Trial
→ Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (From Banyan Hill Publishing) (Ad)tc pixel Free GYRE Stock Alerts

Gyre Therapeutics (GYRE) Institutional Ownership

Gyre Therapeutics logo
$7.67 -0.22 (-2.79%)
Closing price 09/9/2025 04:00 PM Eastern
Extended Trading
$7.68 +0.01 (+0.13%)
As of 09/9/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Gyre Therapeutics (NASDAQ:GYRE)

Current
Institutional Ownership
Percentage
23.99%
Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$5.69M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$489.44K
Get GYRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Gyre Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

GYRE Institutional Buying and Selling by Quarter

Gyre Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025Bank of America Corp DE6,277$46K0.0%+28.8%0.007%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,413$54K0.0%+77.8%0.008%
8/12/2025American Century Companies Inc.11,291$83K0.0%-52.6%0.012%
8/12/2025JPMorgan Chase & Co.6,461$47K0.0%+84.6%0.007%
8/8/2025Geode Capital Management LLC401,709$2.95M0.0%+28.6%0.428%
8/8/2025SBI Securities Co. Ltd.232,299$1.71M0.0%+87.9%0.248%
6/27/2025Goldman Sachs Group Inc.16,147$125K0.0%-38.8%0.017%
5/16/2025Goldman Sachs Group Inc.16,147$125K0.0%-38.8%0.017%
5/14/2025Advantage Alpha Capital Partners LP13,663$105K0.0%+54.0%0.015%
5/13/2025American Century Companies Inc.23,825$184K0.0%N/A0.025%
5/9/2025Charles Schwab Investment Management Inc.111,416$860K0.0%-2.7%0.119%
5/2/2025SBI Securities Co. Ltd.123,629$954K0.0%+22.1%0.132%
4/29/2025Bank of New York Mellon Corp16,492$127K0.0%+18.7%0.018%
4/7/2025GAMMA Investing LLC1,822$140K0.0%+15,083.3%0.002%
2/17/2025Bank of America Corp DE6,937$84K0.0%+40.4%0.007%
2/14/2025Northern Trust Corp103,382$1.25M0.0%+9.1%0.111%
2/13/2025Barclays PLC10,543$128K0.0%+13.5%0.011%
2/13/2025Wells Fargo & Company MN4,016$49K0.0%+29.4%0.004%
2/11/2025Advantage Alpha Capital Partners LP8,873$107K0.0%-66.7%0.009%
2/6/2025Charles Schwab Investment Management Inc.114,566$1.39M0.0%+0.8%0.123%
2/6/2025SBI Securities Co. Ltd.101,239$1.23M0.0%N/A0.108%
2/4/2025Bank of New York Mellon Corp13,896$168K0.0%+11.1%0.015%
11/19/2024Barclays PLC9,288$116K0.0%+281.8%0.010%
11/16/2024Geode Capital Management LLC303,647$3.81M0.0%+16.9%0.325%
11/15/2024Barclays PLC9,288$116K0.0%+281.8%0.010%
11/15/2024State Street Corp104,490$1.31M0.0%+8.8%0.112%
11/13/2024FMR LLC3,742$47K0.0%N/A0.004%
11/13/2024Advantage Alpha Capital Partners LP26,634$334K0.1%N/A0.029%
11/12/2024Charles Schwab Investment Management Inc.113,648$1.43M0.0%+392.2%0.122%
8/14/2024Marshall Wace LLP10,720$128K0.0%-58.0%0.013%
8/9/2024Renaissance Technologies LLC13,900$166K0.0%N/A0.016%
8/9/2024WINTON GROUP Ltd18,467$220K0.0%N/A0.022%
8/1/2024Rhumbline Advisers10,291$123K0.0%N/A0.012%
7/26/2024Bank of New York Mellon Corp18,266$218K0.0%N/A0.021%
5/10/2024Vanguard Group Inc.195,098$3.41M0.0%-1.5%0.228%
(Data available from 1/1/2016 forward)

GYRE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GYRE shares?

During the previous two years, 21 institutional investors and hedge funds held shares of Gyre Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($3.41M), Geode Capital Management LLC ($2.95M), SBI Securities Co. Ltd. ($1.71M), State Street Corp ($1.31M), Northern Trust Corp ($1.25M), Charles Schwab Investment Management Inc. ($860K), and WINTON GROUP Ltd ($220K).Learn more on Gyre Therapeutics' institutional investors.

What percentage of Gyre Therapeutics' stock is owned by institutional investors?

23.99% of Gyre Therapeutics' stock is owned by institutional investors. Learn more on GYRE's institutional investor holdings.

Which institutional investors have been buying Gyre Therapeutics' stock?

Of the 18 institutional investors that purchased Gyre Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: SBI Securities Co. Ltd. ($232.30K), Geode Capital Management LLC ($133.23K), Charles Schwab Investment Management Inc. ($91.48K), Advantage Alpha Capital Partners LP ($31.42K), American Century Companies Inc. ($23.83K), Bank of New York Mellon Corp ($22.25K), and WINTON GROUP Ltd ($18.47K).

How much institutional buying is happening at Gyre Therapeutics?

Institutional investors have bought a total of 564,307 shares in the last 24 months. This purchase volume represents approximately $5.69M in transactions.

Which of Gyre Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Gyre Therapeutics stock in the last 24 months: Goldman Sachs Group Inc. ($20.48K), Advantage Alpha Capital Partners LP ($17.76K), American Century Companies Inc. ($12.53K), and Charles Schwab Investment Management Inc. ($3.15K).

How much institutional selling is happening at Gyre Therapeutics?

Institutional investors have sold a total of 53,923 shares in the last 24 months. This volume of shares sold represents approximately $489.44K in transactions.


Related Companies

This page (NASDAQ:GYRE) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners
“HELIOS”: My No. 1 Investment of the 2020s
A mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...
Stansberry Research | Sponsoredtc pixel
Wall Street legend: “Put $1,000 in this AI stock”
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel